MK0476 Study in Adult Patients With Acute Asthma (0476-322)

MK0476 Phase II/III Placebo Controlled Double Blind Study

This study evaluates the efficacy and safety of MK0476 intravenous administration in adult patients with acute asthma.

Inclusion Criteria:

• Adult Patients With Acute Asthma Attacks

Exclusion Criteria:

• Patient Has Any Known Or Suspected, Acute Or Chronic Cause For Their Pulmonary Symptoms Other Than Asthma (E.G., Copd, Chronic Heart Failure, Etc.)
• Patient Has A Smoking History (20 Cigarettes Per Day) Of More Than 15 Years
• Patient Has A Disease Of The Cardiovascular, Hepatic, Renal, Hematologic Systems, Or Other Severe Disease